Brief: Auris Says Advancing Phase 2 Trial With AM-125 In Acute Vertigo Based On Positive Interim Data

Altamira Therapeutics

17/09/2020 13:06

Sept 17 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL PROVIDES BUSINESS UPDATE AND REPORTS FIRST
HALF
2020 FINANCIAL RESULTS
    * AURIS MEDICAL HOLDING LTD - ADVANCING PHASE 2 TRIAL WITH
AM-125
IN ACUTE VERTIGO BASED ON POSITIVE INTERIM DATA
    * AURIS MEDICAL HOLDING LTD - POSITIVE OUTCOME FROM AM-201
TRIAL
IN PREVENTION OF ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
    * AURIS MEDICAL - ADDITION OF NEW INTRANASAL PROGRAM WITH
DEVELOPMENT OF DRUG-FREE SPRAY FOR PROTECTION AGAINST AIRBORNE
PATHOGENS AND ALLERGENS
    * AURIS MEDICAL HOLDING LTD - REVIEW OF STRATEGIC OPTIONS
INITIATED
    * AURIS MEDICAL HOLDING LTD - BOARD OF DIRECTORS HAS STARTED
A
PROCESS TO EXPLORE, REVIEW AND EVALUATE A BROAD RANGE OF
POTENTIAL STRATEGIC ALTERNATIVES
    * AURIS MEDICAL HOLDING LTD - ALTERNATIVES INCLUDE SALE OR
MERGER
OF COMPANY

Source text for Eikon:  ID:nGNX2Wffr3 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))